University of California Irvine-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of California Irvine - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013484
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of California Irvine (UCI), a subsidiary of University of California is an educational university that provides undergraduate and graduate degree courses and research services. The university provides educational courses in various fields such as business, education, engineering, arts, biological sciences, and school of medicine, social ecology, program in nursing science, interdisciplinary studies, law, medicine, public health, humanities, information and computer sciences; social sciences, pharmaceutical sciences, and physical sciences, among others. The university also supports, promotes and facilitates various research activities. It operates various research activities with the help of research institutions. The university also provides training and education on research activities. UCI is headquartered in Irvine, California, the US.

University of California Irvine – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of California Irvine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of California Irvine, Medical Devices Deals, 2011 to YTD 2017 9
University of California Irvine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of California Irvine, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Novoheart Enters into Research Agreement with University of California Irvine 11
Licensing Agreements 12
Novoheart Enters into Licensing Agreement with University of California Irvine 12
Thesan Pharma Enters into Licensing Agreement with University of California, Irvine 13
ChromaDex Enters Into Licensing Agreement With University Of California, Irvine 14
Repligen Enters Into Licensing Agreement With UCI 15
University of California Irvine – Key Competitors 16
University of California Irvine – Key Employees 17
University of California Irvine – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Government and Public Interest 20
Sep 18, 2017: UCI receives $200 million gift to name College of Health Sciences and launch major integrative health initiative 20
Jul 26, 2017: UCI Stem Cell Therapy Attacks Cancer by Targeting Unique Tissue Stiffness 22
Aug 01, 2016: UCI scientists identify a new approach for treating skin cancer 23
Mar 28, 2016: UCI scientists receive $8 million to help develop Q fever vaccine 24
Feb 29, 2016: Genetic Link to Parkinson’s Disease Is Best Hope for the Future in Rare Disease 25
Product News 26
Jul 05, 2016: Unique Alzheimer’s Disease Vaccines Show Great Potential in Pre-Clinical Studies 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
University of California Irvine, Pharmaceuticals & Healthcare, Key Facts 2
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of California Irvine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of California Irvine, Deals By Therapy Area, 2011 to YTD 2017 8
University of California Irvine, Medical Devices Deals, 2011 to YTD 2017 9
University of California Irvine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Novoheart Enters into Research Agreement with University of California Irvine 11
Novoheart Enters into Licensing Agreement with University of California Irvine 12
Thesan Pharma Enters into Licensing Agreement with University of California, Irvine 13
ChromaDex Enters Into Licensing Agreement With University Of California, Irvine 14
Repligen Enters Into Licensing Agreement With UCI 15
University of California Irvine, Key Competitors 16
University of California Irvine, Key Employees 17
University of California Irvine, Subsidiaries 18

★海外企業調査レポート[University of California Irvine-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd, is an upstream oil and gas exploration and production company. The company explores, produces, and develops, oil and gas properties in Trinidad and Tobago. It holds interests in projects such as South Palo Seco, New …
  • The 77 Bank Ltd:企業の戦略・SWOT・財務情報
    The 77 Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The 77 Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Siemens Ltd (SIEMENS):企業の財務・戦略的SWOT分析
    Siemens Ltd (SIEMENS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Generali Brasil Seguros S.A.:企業の戦略・SWOT・財務情報
    Generali Brasil Seguros S.A. - Strategy, SWOT and Corporate Finance Report Summary Generali Brasil Seguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Monica Healthcare Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Monica Healthcare Ltd (MHL), a subsidiary of GE Healthcare LLC, is a medical device company that develops and commercializes fetal monitoring devices for use during labor and uterine activity applications. The company provides products such as monica AN24 with IF24, monica AN24 with VS progr …
  • CureMeta LLC-製薬・医療分野:企業M&A・提携分析
    Summary CureMeta LLC (CureMeta) is a biotechnology company that concentrates on the development of immunology therapeutics for cancers. The company advances novel antibody drug conjugates targeting pluripotent stem cells. Its pipeline product comprises Bstrongximab-ADC. CureMeta develops the antibod …
  • Lario Oil & Gas Company:石油・ガス:M&Aディール及び事業提携情報
    Summary Lario Oil & Gas Company (Lario Oil & Gas) is an oil and gas exploration and production company that explores and produces oil and gas properties. The company offers services such as discovering reserves organically from geologic thesis, drill-bit, field delineation, and land acquisition and …
  • Fraport Slovenija, d.o.o.:企業の戦略・SWOT・財務情報
    Fraport Slovenija, d.o.o. - Strategy, SWOT and Corporate Finance Report Summary Fraport Slovenija, d.o.o. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Voith Hydro Holding GmbH & Co KG:企業の戦略的SWOT分析
    Voith Hydro Holding GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Fortum Corporation (FORTUM):石油・ガス:M&Aディール及び事業提携情報
    Summary Fortum Corp (Fortum) is a clean energy company, which generates, distributes and sells heat and electricity. The company undertakes operation and maintenance of power plants; and offers energy-related services. Fortum's operational assets include hydropower plants, condensing power plants, w …
  • Graphic Packaging Holding Company:企業のM&A・事業提携・投資動向
    Graphic Packaging Holding Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Graphic Packaging Holding Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Copalis:戦略・SWOT・企業財務分析
    Copalis - Strategy, SWOT and Corporate Finance Report Summary Copalis - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Yildiz Holding Inc:企業の戦略的SWOT分析
    Yildiz Holding Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • The Better Drinks Co Limited:企業の戦略・SWOT・財務情報
    The Better Drinks Co Limited - Strategy, SWOT and Corporate Finance Report Summary The Better Drinks Co Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Toray Industries Inc (3402):電力:M&Aディール及び事業提携情報
    Summary Toray Industries Inc (Toray) is a provider of advanced materials. The company's product portfolio includes fibers, fashion apparel, plastics, chemicals, IT-related products, composite materials, life sciences products, and medical devices, pharmaceuticals, and optical products. It provides i …
  • Ei Group plc:戦略・SWOT・企業財務分析
    Ei Group plc - Strategy, SWOT and Corporate Finance Report Summary Ei Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • AeroCentury Corp:企業の戦略・SWOT・財務分析
    AeroCentury Corp - Strategy, SWOT and Corporate Finance Report Summary AeroCentury Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ezra Holdings Ltd-石油・ガス分野:企業M&A・提携分析
    Summary Ezra Holdings Limited (Ezra Holdings) is an offshore contractor and provider of integrated offshore solutions to the oil and gas industry. The group's service portfolio consists of subsea construction and maintenance, drilling support, towing and mooring, pipe and cable operations, high spee …
  • Hurricane Energy plc (HUR):企業の財務・戦略的SWOT分析
    Summary Hurricane Energy Plc (Hurricane) is an oil and gas exploration and development company that discovers and develops oil from fractured basement reservoirs. The company provides exploration properties such as lancaster basement prospect, whirlwind basement discovery, lincoln basement prospect, …
  • G1 Therapeutics Inc (GTHX):製薬・医療:M&Aディール及び事業提携情報
    Summary G1 Therapeutics Inc (G1 Therapeutics), formerly G Zero Therapeutics Inc, is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of cancer. The company’s pipeline products include trilaciclib (G1T28), a CDK4/6 inhibitor to pres …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆